rs149170280

Variant summary

Our verdict is Likely benign. The variant received -2 ACMG points: 0P and 2B. BP4_Moderate

The NM_001146262.4(SYT14):​c.202A>G​(p.Arg68Gly) variant causes a missense change. The variant allele was found at a frequency of 0.000778 in 1,612,266 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).

Frequency

Genomes: 𝑓 0.00041 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00082 ( 1 hom. )

Consequence

SYT14
NM_001146262.4 missense

Scores

4
15

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:3

Conservation

PhyloP100: 5.23

Publications

2 publications found
Variant links:
Genes affected
SYT14 (HGNC:23143): (synaptotagmin 14) This gene is a member of the synaptotagmin gene family and encodes a protein similar to other family members that mediate membrane trafficking in synaptic transmission. The encoded protein is a calcium-independent synaptotagmin. Mutations in this gene are a cause of autosomal recessive spinocerebellar ataxia-11 (SCAR11), and a t(1;3) translocation of this gene has been associated with neurodevelopmental abnormalities. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene, and a pseudogene of this gene is located on the long arm of chromosome 4. [provided by RefSeq, Dec 2011]
SYT14 Gene-Disease associations (from GenCC):
  • autosomal recessive spinocerebellar ataxia 11
    Inheritance: AR, Unknown Classification: SUPPORTIVE, LIMITED Submitted by: Orphanet, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -2 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.06872484).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SYT14NM_001146262.4 linkc.202A>G p.Arg68Gly missense_variant Exon 3 of 9 ENST00000367019.6 NP_001139734.1 Q8NB59-6

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SYT14ENST00000367019.6 linkc.202A>G p.Arg68Gly missense_variant Exon 3 of 9 1 NM_001146262.4 ENSP00000355986.1 Q8NB59-6

Frequencies

GnomAD3 genomes
AF:
0.000414
AC:
63
AN:
152160
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000724
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000131
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000838
Gnomad OTH
AF:
0.000478
GnomAD2 exomes
AF:
0.000324
AC:
81
AN:
250216
AF XY:
0.000288
show subpopulations
Gnomad AFR exome
AF:
0.0000627
Gnomad AMR exome
AF:
0.0000580
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000626
Gnomad OTH exome
AF:
0.00115
GnomAD4 exome
AF:
0.000816
AC:
1192
AN:
1460106
Hom.:
1
Cov.:
31
AF XY:
0.000756
AC XY:
549
AN XY:
726244
show subpopulations
African (AFR)
AF:
0.000210
AC:
7
AN:
33400
American (AMR)
AF:
0.000112
AC:
5
AN:
44608
Ashkenazi Jewish (ASJ)
AF:
0.0000383
AC:
1
AN:
26090
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39612
South Asian (SAS)
AF:
0.00
AC:
0
AN:
85832
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53372
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5330
European-Non Finnish (NFE)
AF:
0.000997
AC:
1108
AN:
1111588
Other (OTH)
AF:
0.00118
AC:
71
AN:
60274
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.473
Heterozygous variant carriers
0
56
112
168
224
280
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
46
92
138
184
230
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000414
AC:
63
AN:
152160
Hom.:
0
Cov.:
32
AF XY:
0.000336
AC XY:
25
AN XY:
74330
show subpopulations
African (AFR)
AF:
0.0000724
AC:
3
AN:
41448
American (AMR)
AF:
0.000131
AC:
2
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5186
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4834
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10610
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.000838
AC:
57
AN:
68004
Other (OTH)
AF:
0.000478
AC:
1
AN:
2092
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
4
9
13
18
22
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000645
Hom.:
0
Bravo
AF:
0.000400
TwinsUK
AF:
0.000539
AC:
2
ALSPAC
AF:
0.00182
AC:
7
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000698
AC:
6
ExAC
AF:
0.000288
AC:
35
EpiCase
AF:
0.00109
EpiControl
AF:
0.000771

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Uncertain:2
Oct 01, 2019
CeGaT Center for Human Genetics Tuebingen
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

May 21, 2024
Athena Diagnostics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Available data are insufficient to determine the clinical significance of the variant at this time. The frequency of this variant in the general population is higher than would generally be expected for pathogenic variants in this gene. (http://gnomad.broadinstitute.org) Polyphen and MutationTaster predict this amino acid change may be benign. -

not specified Uncertain:1
Sep 09, 2024
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.337A>G (p.R113G) alteration is located in exon 4 (coding exon 4) of the SYT14 gene. This alteration results from a A to G substitution at nucleotide position 337, causing the arginine (R) at amino acid position 113 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.086
BayesDel_addAF
Benign
-0.47
T
BayesDel_noAF
Benign
-0.47
CADD
Benign
20
DANN
Uncertain
1.0
DEOGEN2
Benign
0.0058
.;.;.;T;.
Eigen
Benign
-0.18
Eigen_PC
Benign
-0.018
FATHMM_MKL
Uncertain
0.94
D
LIST_S2
Uncertain
0.91
D;D;D;D;.
M_CAP
Benign
0.0039
T
MetaRNN
Benign
0.069
T;T;T;T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
0.63
N;.;.;N;.
PhyloP100
5.2
PrimateAI
Benign
0.35
T
PROVEAN
Benign
-0.60
N;N;.;N;N
REVEL
Benign
0.089
Sift
Uncertain
0.018
D;D;.;D;D
Sift4G
Benign
0.35
T;T;T;T;T
Polyphen
0.10
B;.;.;B;.
Vest4
0.36
MVP
0.043
ClinPred
0.042
T
GERP RS
3.9
Varity_R
0.087
gMVP
0.33
Mutation Taster
=78/22
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs149170280; hg19: chr1-210187118; API